PZJ — Lynch Syndrome Test System Class II

FDA Device Classification

FDA product code PZJ covers "Lynch Syndrome Test System", a Class II medical device regulated under 21 CFR 864.1866. Submissions are reviewed by the Immunology panel. At least 5 recent 510(k) clearances have been granted under this product code.

Classification details

Product Code
PZJ
Device Class
Class II
Regulation Number
864.1866
Submission Type
510(k)
Review Panel
PA
Medical Specialty
Immunology
Implant
No

Definition

The Lynch syndrome test system is used to identify loss of DNA mismatch repair proteins or microsatellite instability in tumor tissue from cancer patients for the purpose of identifying patients who may benefit from additional testing for the inherited cancer predisposition Lynch Syndrome

Recent 510(k) clearances

K-NumberApplicantDevice NameDate
K260776Roche Tissue DiagnosticsVENTANA MMR IHC PanelOct 23, 2026
K211181BiocartisIdylla MSI TestFeb 27, 2023
K213348Leica Biosystems NewcastleBOND MMR Antibody PanelFeb 21, 2023
K200129Promega CorporationOncoMate MSI Dx Analysis SystemJul 26, 2021
DEN170030Ventana Medical SystemsVENTANA anti-MLH-1(M1) Mouse Monoclonal Primary Antibody, VENTANA anti-PMS2…Oct 27, 2017

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.